The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
Open accessAbstract
All malignant cancers, whether inherited or sporadic, are fundamentally governed by Darwinian dynamics. The process of carcinogenesis requires genetic instability and highly selective local microenvironments, the combination of which promotes somatic evolution. These microenvironmental forces, specifically hypoxia, acidosis and reactive oxygen species, are not only highly selective, but are also able to induce genetic instability. As a result, malignant cancers are dynamically evolving clades of cells living in distinct microhabitats that almost certainly ensure the emergence of therapy-resistant populations. Cytotoxic cancer therapies also impose intense evolutionary selection pressures on the surviving cells and thus increase the evolutionary rate. Importantly, the principles of Darwinian dynamics also embody fundamental principles that can illuminate strategies for the successful management of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109653 · Cited by 2,863
Jacob, F. (1977) · Science · doi:10.1126/science.860134 · Cited by 2,690
Cancer is a preventable disease that requires major lifestyle changes
Anand, P., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., Sung, B., & Aggarwal, B. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9661-9 · Cited by 2,632
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Dysregulated pH: a perfect storm for cancer progression
Webb, B. A., Chimenti, M., Jacobson, M. P., & Barber, D. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3110 · Cited by 2,237
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Marty, M., Cognetti, F., Maraninchi, D., Snyder, R., Mauriac, L., Tubiana-Hulin, M., Chan, S., Grimes, D., Antón, A., Lluch, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.173 · Cited by 1,597
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
Targeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,330
(1991) · PubMed · Cited by 1,305
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., & Parsons, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 946
Blackwell, K. L., Burstein, H. J., Storniolo, A. M., Rugo, H., Sledge, G., Koehler, M., Ellis, C., Casey, M., Vukelja, S., Bischoff, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4437 · Cited by 942
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J. K. V., Markowitz, S., Zhou, S., et al. (2009) · Science · doi:10.1126/science.1174229 · Cited by 914
Gatenby, R. A., Silva, A. S., Gillies, R. J., & Frieden, B. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3658 · Cited by 846
Self-citationComparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Antal, T., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 818
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
Acid-Mediated Tumor Invasion: a Multidisciplinary Study
Gatenby, R. A., Gawlinski, E. T., Gmitro, A. F., Kaylor, B., & Gillies, R. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4193 · Cited by 771
Self-citationGenetic instability and darwinian selection in tumours
Cahill, D. P., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01661-x · Cited by 748
A microenvironmental model of carcinogenesis
Gatenby, R. A., & Gillies, R. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2255 · Cited by 721
Self-citationHereditary Cancer Predisposition Syndromes
Garber, J. E., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.042 · Cited by 697
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
Michelakis, E. D., Webster, L., & Mackey, J. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604554 · Cited by 656
Causes and Consequences of Increased Glucose Metabolism of Cancers
Gillies, R. J., Robey, I., & Gatenby, R. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047258 · Cited by 623
Self-citationBrechot, C., Pourcel, C., Louise, A., Rain, B., & Tiollais, P. (1980) · Nature · doi:10.1038/286533a0 · Cited by 612
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Wojtkowiak, J. W., Verduzco, D., Schramm, K. J., & Gillies, R. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200292c · Cited by 566
Self-citationTargeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
Chan, D. A., Sutphin, P. D., Nguyen, P., Turcotte, S., Lai, E. W., Banh, A., Reynolds, G. E., Chi, J.-T., Wu, J., Solow-Cordero, D. E., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002394 · Cited by 557
Acceleration of Emergence of Bacterial Antibiotic Resistance in Connected Microenvironments
Zhang, Q., Lambert, G., Liao, D., Kim, H., Robin, K., Tung, C.-K., Pourmand, N., & Austin, R. H. (2011) · Science · doi:10.1126/science.1208747 · Cited by 539
Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling
Chmielecki, J., Foo, J., Oxnard, G. R., Hutchinson, K., Ohashi, K., Somwar, R., Wang, L., Amato, K. R., Arcila, M., Sos, M. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002356 · Cited by 525
The Mechanisms of UV Mutagenesis
IKEHATA, H., & ONO, T. (2011) · Journal of Radiation Research · doi:10.1269/jrr.10175 · Cited by 522
Untch, M., Fasching, P. A., Konecny, G. E., Hasmüller, S., Lebeau, A., Kreienberg, R., Camara, O., Müller, V., du Bois, A., Kühn, T., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.4930 · Cited by 506
Genotoxicity of tobacco smoke and tobacco smoke condensate: a review
DeMarini, D. M. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.02.001 · Cited by 496
23 Genetic instability induced by the tumor microenvironment
Glazer, P. M., Reynolds, T. Y., & Rockwell, S. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)80581-0 · Cited by 427
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
Gerlinger, M., & Swanton, C. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605912 · Cited by 421
Drug resistance in cancer: Principles of emergence and prevention
Komarova, N. L., & Wodarz, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501870102 · Cited by 414
An overview of cancer multidrug resistance: a still unsolved problem
Lage, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8111-5 · Cited by 408
Human cancers express mutator phenotypes: origin, consequences and targeting
Loeb, L. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3063 · Cited by 396
Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells
Young, S. D., Marshall, R. S., & Hill, R. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9533 · Cited by 381
Kimura, H., Braun, R. D., Ong, E. T., Hsu, R., Secomb, T. W., Papahadjopoulos, D., Hong, K., & Dewhirst, M. W. (1996) · PubMed · Cited by 364
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Mirski, S. E. L., Gerlach, J. H., & Cole, S. P. C. (1987) · PubMed · Cited by 351
31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate
Gillies, R. J., Liu, Z., & Bhujwalla, Z. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.1.c195 · Cited by 351
Self-citationIn vivo imaging of extracellular pH using1H MRSI
van Sluis, R., Bhujwalla, Z. M., Raghunand, N., Ballesteros, P., Alvarez, J., Cerd�n, S., Galons, J.-P., & Gillies, R. J. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199904)41:4<743::aid-mrm13>3.0.co;2-z · Cited by 322
Self-citationPatterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
Iwamoto, F. M., Abrey, L. E., Beal, K., Gutin, P. H., Rosenblum, M. K., Reuter, V. E., DeAngelis, L. M., & Lassman, A. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc0184 · Cited by 305
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?
De Bock, K., Mazzone, M., & Carmeliet, P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.83 · Cited by 293
Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
Allred, D. C., Wu, Y., Mao, S., Nagtegaal, I. D., Lee, S., Perou, C. M., Mohsin, S. K., O'Connell, P., Tsimelzon, A., & Medina, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1127 · Cited by 285
Hammond, E. M., Dorie, M. J., & Giaccia, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212360200 · Cited by 284
Acquired resistance to tyrosine kinase inhibitors during cancer therapy
Engelman, J. A., & Settleman, J. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.004 · Cited by 284
Decreased Expression of the DNA Mismatch Repair Gene Mlh1 under Hypoxic Stress in Mammalian Cells
Mihaylova, V. T., Bindra, R. S., Yuan, J., Campisi, D., Narayanan, L., Jensen, R., Giordano, F., Johnson, R. S., Rockwell, S., & Glazer, P. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3265-3273.2003 · Cited by 274
Hashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V., & Gillies, R. J. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1644 · Cited by 265
Self-citationShi, Q., Abbruzzese, J. L., Huang, S., Fidler, I. J., Xiong, Q., & Xie, K. (1999) · PubMed · Cited by 261
Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors
Davies, P. C. W., & Lineweaver, C. H. (2011) · Physical Biology · doi:10.1088/1478-3975/8/1/015001 · Cited by 256
Clinical radioimmunotherapy—the role of radiobiology
Pouget, J.-P., Navarro-Teulon, I., Bardiès, M., Chouin, N., Cartron, G., Pèlegrin, A., & Azria, D. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.160 · Cited by 250
Rice, G. C., Hoy, C., & Schimke, R. T. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5978 · Cited by 249
Wykoff, C. C., Beasley, N., Watson, P. H., Campo, L., Chia, S. K., English, R., Pastorek, J., Sly, W. S., Ratcliffe, P., & Harris, A. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64048-5 · Cited by 249
Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs
Duan, J.-X., Jiao, H., Kaizerman, J., Stanton, T., Evans, J. W., Lan, L., Lorente, G., Banica, M., Jung, D., Wang, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701028q · Cited by 239
Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
Gillies, R. J., & Gatenby, R. A. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9085-y · Cited by 219
Self-citationDynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology
Knopp, M. V., Giesel, F. L., Marcos, H. B., von Tengg‐Kobligk, H., & Choyke, P. L. (2001) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-200108000-00006 · Cited by 215
Radu, C. G., Nijagal, A., McLaughlin, J., Wang, L., & Witte, O. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409415102 · Cited by 211
Clastogenicity of low pH to various cultured mammalian cells
Morita, T., Nagaki, T., Fukuda, I., & Okumura, K. (1992) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(92)90235-t · Cited by 210
Houghton, P. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1314 · Cited by 208
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
Meng, F., Evans, J. W., Bhupathi, D., Banica, M., Lan, L., Lorente, G., Duan, J.-X., Cai, X., Mowday, A. M., Guise, C. P., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0634 · Cited by 203
Sun, J. D., Liu, Q., Wang, J., Ahluwalia, D., Ferraro, D., Wang, Y., Duan, J.-X., Ammons, W. S., Curd, J. G., Matteucci, M. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1980 · Cited by 190
Abrahamsson, P.-A. (2010) · European Urology · doi:10.1016/j.eururo.2009.07.049 · Cited by 187
Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells
Madhok, B. M., Yeluri, S., Perry, S. L., Hughes, T. A., & Jayne, D. G. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605701 · Cited by 180
Ludwig, H., Khayat, D., Giaccone, G., & Facon, T. (2005) · Cancer · doi:10.1002/cncr.21414 · Cited by 179
TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies
Holoch, P. A., & Griffith, T. S. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.066 · Cited by 178
Targeted CML therapy: controlling drug resistance, seeking cure
O’Hare, T., Corbin, A. S., & Druker, B. J. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.11.002 · Cited by 178
Proteins, drug targets and the mechanisms they control: the simple truth about complex networks
Araujo, R. P., Liotta, L. A., & Petricoin, E. F. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2381 · Cited by 172
Bindra, R. S., & Glazer, P. M. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.03.013 · Cited by 168
Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer
Jain, R. K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2346 · Cited by 165
Current status of genome-wide association studies in cancer
Chung, C. C., & Chanock, S. J. (2011) · Human Genetics · doi:10.1007/s00439-011-1030-9 · Cited by 164
Lessons from Applied Ecology: Cancer Control Using an Evolutionary Double Bind
Gatenby, R. A., Brown, J., & Vincent, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1354 · Cited by 163
Self-citationMassarweh, S., & Schiff, R. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01273 · Cited by 159
Fitness Trade-Offs and Environmentally Induced Mutation Buffering in Isogenic C. elegans
Casanueva, M. O., Burga, A., & Lehner, B. (2012) · Science · doi:10.1126/science.1213491 · Cited by 146
Chromosomal Abnormalities in Human Neoplasia
Sandberg, A. A., & Hossfeld, D. K. (1970) · Annual Review of Medicine · doi:10.1146/annurev.me.21.020170.002115 · Cited by 146
Leffler, A., Mönter, B., & Koltzenburg, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.020 · Cited by 142
Hypoxia-Induced Epigenetic Regulation and Silencing of the BRCA1 Promoter
Lü, Y., Chu, A., Turker, M. S., & Glazer, P. M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01121-10 · Cited by 141
Magnetic resonance image–guided proteomics of human glioblastoma multiforme
Hobbs, S. K., Shi, G., Homer, R., Harsh, G., Atlas, S. W., & Bednarski, M. D. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10395 · Cited by 139
Environmental factors as regulators and effectors of multistep carcinogenesis
Minamoto, T., Mai, M., & Ronai, Z. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.4.519 · Cited by 139
Michiels, F.-M., Chappuis, S., Caillou, B., Pasini, A., Talbot, M., Monier, R., Lenoir, G., Feunteun, J., & Billaud, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3330 · Cited by 138
Chitneni, S. K., Palmer, G. M., Zalutsky, M. R., & Dewhirst, M. W. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.075663 · Cited by 137
Systemic Buffers Inhibit Carcinogenesis in TRAMP Mice
Ibrahim‐Hashim, A., Cornnell, H. H., Abrahams, D. F., Lloyd, M. C., Bui, M. M., Gillies, R. J., & Gatenby, R. A. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.03.113 · Cited by 133
Self-citationChromosomal Instability Substantiates Poor Prognosis in Patients with Diffuse Large B-cell Lymphoma
Bakhoum, S. F. W., Danilova, O. V., Kaur, P., Levy, N. B., & Compton, D. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2049 · Cited by 133
Cancer nanomedicines targeting tumor extracellular pH
Li, T. X., & Bae, Y. H. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.10.039 · Cited by 130
3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy
Ganapathy‐Kanniappan, S., Vali, M., Kunjithapatham, R., Buijs, M., Syed, L. H., Rao, P. P., Ota, S., Kwak, B. K., Loffroy, R., & Geschwind, J. F. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110791591427 · Cited by 128
Behr, T. M., Béhé, M. P., Stabin, M. G., Wehrmann, E., Apostolidis, C., Molinet, R., Strutz, F., Fayyazi, A., Wieland, E., Gratz, S., et al. (1999) · PubMed · Cited by 127
Quantifying spatial heterogeneity in dynamic contrast‐enhanced MRI parameter maps
Rose, C. J., Mills, S. J., O'Connor, J. P. B., Buonaccorsi, G. A., Roberts, C., Watson, Y., Cheung, S., Zhao, S., Whitcher, B., Jackson, A., et al. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22003 · Cited by 125
Zytologische Untersuchungen �ber die Natur maligner Tumoren
Winge, �. (1930) · Cell and Tissue Research · doi:10.1007/bf00372971 · Cited by 124
Drew, P. J., Chatterjee, S., Turnbull, L. W., Read, J., Carleton, P. J., Fox, J. N., Monson, J. R. T., & Kerin, M. J. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0599-x · Cited by 119
Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research
Aktipis, A., Kwan, V. S. Y., Johnson, K. A., Neuberg, S. L., & Maley, C. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026100 · Cited by 112
Zhang, H. Y., Hormi-Carver, K. K., Zhang, X., Spechler, S. J., & Souza, R. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2518 · Cited by 106
Gatenby, R. A., Gillies, R. J., & Brown, J. S. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3036 · Cited by 99
Self-citationAcidic pH induces topoisomerase II-mediated DNA damage
Xiao, H., Li, T., Yang, J., & Liu, L. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0935978100 · Cited by 96
Reduction of metastasis using a non-volatile buffer
Hashim, A. I., Cornnell, H. H., Ribeiro, M. D. L. C., Abrahams, D. F., Cunningham, J. J., Lloyd, M. C., Martinez, G. V., Gatenby, R. A., & Gillies, R. J. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9415-7 · Cited by 95
Self-citationRichman, C. M., DeNardo, S. J., OʼDonnell, R. T., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0211 · Cited by 87
Kaminskas, L. M., McLeod, V. M., Kelly, B. D., Cullinane, C. M., Sberna, G., Williamson, M., Boyd, B. J., Owen, D. J., & Porter, C. J. H. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200522d · Cited by 73
The Tumor Microenvironment and DNA Repair
Klein, T. J., & Glazer, P. M. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.006 · Cited by 58
Microenvironmental influences on mutagenesis in mammary epithelial cells
Papp-Szabó, E., Josephy, P. D., & Coomber, B. L. (2005) · International Journal of Cancer · doi:10.1002/ijc.21088 · Cited by 47
Dong, X., Ko, K. H., Chow, J., Tuo, B., Barrett, K. E., & Dong, H. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02207.x · Cited by 38
Kawata, Y., Niki, N., Ohmatsu, H., Kusumoto, M., Tsuchida, T., Eguchi, K., Kaneko, M., & Moriyama, N. (2012) · Medical Physics · doi:10.1118/1.3679017 · Cited by 35
Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro
Wilkinson, D., Sandhu, J., Breneman, J. W., Jd, T., & Birnboim, H. C. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.492 · Cited by 31
Costouros, N. G., Lorang, D., Zhang, Y., Miller, M. S., Diehn, F. E., Hewitt, S. M., Knopp, M. V., Li, K. C., Choyke, P. L., Alexander, H. R., et al. (2002) · Molecular Imaging · doi:10.1162/153535002760235481 · Cited by 28
Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors
Chatal, J., Davodeau, F., Chérel, M., & Barbet, J. (2009) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.55139 · Cited by 27
Venkatasubramanian, R., Arenas, R. B., Henson, M. A., & Forbes, N. S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605773 · Cited by 26
Goncharova, E. I., Nadas, A. J., & Rossman, T. G. (1996) · PubMed · Cited by 23
New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma
Agulnik, M. (2011) · Cancer · doi:10.1002/cncr.26361 · Cited by 22
Beex, L. V. A. M., Rose, C., Mouridsen, H. T., Jassem, J., Nooij, M. A., Estape, J., Paridaens, R., Piccart, M. J., Gorlia, T., Lardenoije, S., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.020 · Cited by 20
Ōtsuka, J. (2011) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2011.03.006 · Cited by 6
Cited by
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
Stincone, A., Prigione, A., Cramer, T., Wamelink, M. M. C., Campbell, K., Cheung, E., Olin‐Sandoval, V., Grüning, N., Krüger, A., Tauqeer Alam, M., et al. (2015) · Biological Reviews · doi:10.1111/brv.12140 · Cited by 1,576
Schürch, C. M., Bhate, S. S., Barlow, G. L., Phillips, D. J., Noti, L., Zlobec, I., Chu, P., Black, S., Demeter, J., McIlwain, D. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.005 · Cited by 1,064
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050
Metadata
- Authors
- Gillies, R. J., Verduzco, D., & Gatenby, R. A.
- Venue
- Nature Reviews Cancer
- Published
- 2012-06-14
- Volume
- 12
- Issue
- 7
- Pages
- 487-493
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2035189255
- Cited by
- 684
- References
- 121
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.